Chairman – Division of Pediatrics and Department of Woman’s and Child’s Health, University Hospital of Padua, Padua, Italy
Rachel is Honorary Nurse Adviser Children’s Cancer at the Leeds Teaching Hospitals Trust in the UK. She spent more than thirty years working in paediatric oncology and haematology in Leeds, and has been involved in developing services for children and young people with cancer in the UK at the local and national level. Rachel is […]
Gabriele Calaminus is a member of the Global Advocacy Working Group and a Past-President of the International Society of Paediatric Oncology (SIOP). An international expert on germ cell tumors and quality of life, Prof. Calaminus is with the Department of Paediatric Hematology and Oncology at the University Children’s Hospital in Bonn (Germany). Prof. Calaminus is […]
Types of membership SIOP offers the following types of membership: Ordinary Members Health and science professionals at the doctorate level (or equivalent degree) who have an exclusive or predominant interest in the clinical, laboratory, epidemiologic or other research application to the field of childhood cancer. € 185 Ordinary Members from Supported Countries Health and science […]
Have you made a difference for children with cancer? SIOP “Making a difference” The International Society of Paediatric Oncology (SIOP) has over 1,000 members who are doctors, nurses and scientists trying to make a difference for children with cancer. SIOP celebrates people who have made a difference for children with cancer by showcasing their contribution […]
Today’s profile is of Ms. Laura Tan, who works at the VIVA-University Children’s Cancer Centre at the National University Hospital as an Outreach Program Senior Nursing Lecturer where she focuses on expanding Nursing Training in the Asia Pacific Region.
The next GHN Traditional and Complementary Medicine Working Group Meeting is scheduled for Wednesday, 29 May, 2024, at 12:00pm EST.
The role of the SIOP Epidemiology and Outcomes Network in the international pediatric oncology community is particularly valuable. Given the rarity of childhood cancers, international collaboration is crucial to sufficiently power epidemiologic and data-driven studies.